We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Technology 4 Venture Capital Trust Plc | LSE:OXF | London | Ordinary Share | GB00B01H4V84 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOXF The Board notes that on 3 June 2021 Arecor Therapeutics plc ("Arecor"), one of Oxford Technology 4 VCT Plc's ("OT4") investee companies, floated on AIM raising GBP20m via a placing at 226p per Arecor share. The flotation was a success and the Arecor bid price at close had risen to 238p per Arecor share. The most recently published unaudited net asset value (NAV) for OT4 at 30 November 2020 was 28.8p per share. Compared to this last published OT4 NAV, the impact of the Arecor flotation in isolation is an increase in the OT4 NAV of GBP673k, or 5.8p per OT4 share. Further detail -- including an updated OT4 NAV as at 28 February 2021 and 31 May 2021 -- will be available in the annual report which is expected to be released towards the end of this month. For further information contact: Oxford Technology Management Lucius Cary 01865 784466
(END) Dow Jones Newswires
June 07, 2021 02:00 ET (06:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Oxford Technology 4 Vent... Chart |
1 Month Oxford Technology 4 Vent... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions